Stocks and InvestingStocks and Investing
Fri, May 27, 2022
Thu, May 26, 2022
Wed, May 25, 2022
Tue, May 24, 2022

Liisa Bayko Maintained (VRTX) at Buy and Held Target at $278 on, May 24th, 2022


Published on 2024-10-27 21:16:30 - WOPRAI, Liisa Bayko
  Print publication without navigation


Liisa Bayko of Evercore ISI Group, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy and Held Target at $278 on, May 24th, 2022.

Liisa has made no other calls on VRTX in the last 4 months.



There are 11 other peers that have a rating on VRTX. Out of the 11 peers that are also analyzing VRTX, 6 agree with Liisa's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • David Risinger of "SVB Leerink" Initiated at Hold and Held Target at $265 on, Monday, May 23rd, 2022
  • Do Kim of "Piper Sandler" Maintained at Hold with Decreased Target to $242 on, Friday, May 6th, 2022
  • Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $267 on, Friday, May 6th, 2022
  • Brian Skorney of "Baird" Downgraded from Buy to Hold on, Friday, May 6th, 2022
  • Paul Matteis of "Stifel" Maintained at Hold with Increased Target to $240 on, Thursday, May 5th, 2022
  • Matthew Harrison of "Morgan Stanley" Upgraded from Sell to Hold and Held Target at $250 on, Tuesday, May 3rd, 2022


These are the ratings of the 5 analyists that currently disagree with Liisa


  • Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $305 on, Friday, May 6th, 2022
  • Gena Wang of "Barclays" Maintained at Buy and Held Target at $291 on, Thursday, May 5th, 2022
  • Colin Bristow of "UBS" Maintained at Strong Buy with Decreased Target to $322 on, Wednesday, April 27th, 2022
  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $350 on, Monday, April 4th, 2022
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy and Held Target at $275 on, Thursday, January 27th, 2022